Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Matt Norton"'
Autor:
Craig W. Ritchie, Tom C. Russ, Sube Banerjee, Bob Barber, Andrew Boaden, Nick C. Fox, Clive Holmes, Jeremy D. Isaacs, Ira Leroi, Simon Lovestone, Matt Norton, John O’Brien, Jim Pearson, Richard Perry, James Pickett, Adam D. Waldman, Wai Lup Wong, Martin N. Rossor, Alistair Burns
Publikováno v:
Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-7 (2017)
Abstract Context This commentary discusses the implications of disease-modifying treatments for Alzheimer’s disease which seem likely to appear in the next few years and results from a meeting of British experts in neurodegenerative diseases in Edi
Externí odkaz:
https://doaj.org/article/ed8e19615da448feb63fc2df8cf0c64d
Autor:
Craig W. Ritchie, Tom C. Russ, Sube Banerjee, Bob Barber, Andrew Boaden, Nick C. Fox, Clive Holmes, Jeremy D. Isaacs, Ira Leroi, Simon Lovestone, Matt Norton, John O’Brien, Jim Pearson, Richard Perry, James Pickett, Adam D. Waldman, Wai Lup Wong, Martin N. Rossor, Alistair Burns
Publikováno v:
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-2 (2018)
Since the publication of this article [1], it has come to the attention of the authors that information for one of the authors was not included in the competing interests section. Craig Richie has declared potential competing interests with the follo
Externí odkaz:
https://doaj.org/article/cfb1c61369304b6fb9a2a412101f8ad5
Autor:
Neeraj, Vij, Olivia, Newgaard, Matt, Norton, Hannah, Tolson, Alan D, Kaye, Omar, Viswanath, Ivan, Urits
Publikováno v:
Orthop Rev (Pavia)
Introduction Anterior Cruciate Ligament tears are common after a non-contact injury and several thousand reconstructions (ACLR) occur yearly in the United States. Multimodal pain management has evolved greatly to include nerve blocks to minimize phys
Autor:
Alistair Burns, Jim Pearson, John T. O'Brien, Wai Lup Wong, James Pickett, Adam D. Waldman, Tom C. Russ, Jeremy D. Isaacs, Clive Holmes, Bob Barber, Craig W. Ritchie, Ira Leroi, Matt Norton, Martin N. Rossor, Sube Banerjee, Richard Perry, Andrew Boaden, Simon Lovestone, Nick C. Fox
Publikováno v:
Alzheimer's Research & Therapy
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-2 (2018)
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-2 (2018)
Context This commentary discusses the implications of disease-modifying treatments for Alzheimer’s disease which seem likely to appear in the next few years and results from a meeting of British experts in neurodegenerative diseases in Edinburgh. T
Autor:
Nick C. Fox, Martin N. Rossor, Sube Banerjee, Richard Perry, Jim Pearson, Wai Lup Wong, John T. O'Brien, James Pickett, Tom C. Russ, Andrew Boaden, Clive Holmes, Bob Barber, Alistair Burns, Adam D. Waldman, Craig W. Ritchie, Matt Norton, Simon Lovestone, Jeremy D. Isaacs, Ira Leroi
Publikováno v:
Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-7 (2017)
Alzheimer's Research & Therapy
Ritchie, C, Russ, T, Banerjee, S, Barber, B, Boaden, A, Fox, N C, Holmes, C, Isaacs, J D, Leroi, I, Lovestone, S, Norton, M, O'Brien, J, Pearson, J, Perry, R, Pickett, J, Waldman, A, Lup Wong, W, Rossor, M N & Burns, A 2017, ' The Edinburgh Consensus: Preparing for the advent of disease-modifying therapies for Alzheimer's disease ', Alzheimer's research & therapy . https://doi.org/10.1186/s13195-017-0312-4
Ritchie, C W, Russ, T C, Banerjee, S, Barber, B, Boaden, A, Fox, N C, Holmes, C, Isaacs, J D, Leroi, I, Lovestone, S, Norton, M, O'Brien, J, Pearson, J, Perry, R, Pickett, J, Waldman, A D, Wong, W L, Rossor, M N & Burns, A 2017, ' The Edinburgh Consensus : Preparing for the advent of disease-modifying therapies for Alzheimer's disease ', Alzheimer's Research and Therapy, vol. 9, no. 1, 85 . https://doi.org/10.1186/s13195-017-0312-4
Alzheimer's Research & Therapy
Ritchie, C, Russ, T, Banerjee, S, Barber, B, Boaden, A, Fox, N C, Holmes, C, Isaacs, J D, Leroi, I, Lovestone, S, Norton, M, O'Brien, J, Pearson, J, Perry, R, Pickett, J, Waldman, A, Lup Wong, W, Rossor, M N & Burns, A 2017, ' The Edinburgh Consensus: Preparing for the advent of disease-modifying therapies for Alzheimer's disease ', Alzheimer's research & therapy . https://doi.org/10.1186/s13195-017-0312-4
Ritchie, C W, Russ, T C, Banerjee, S, Barber, B, Boaden, A, Fox, N C, Holmes, C, Isaacs, J D, Leroi, I, Lovestone, S, Norton, M, O'Brien, J, Pearson, J, Perry, R, Pickett, J, Waldman, A D, Wong, W L, Rossor, M N & Burns, A 2017, ' The Edinburgh Consensus : Preparing for the advent of disease-modifying therapies for Alzheimer's disease ', Alzheimer's Research and Therapy, vol. 9, no. 1, 85 . https://doi.org/10.1186/s13195-017-0312-4
Context: This article discusses the implications of disease-modifying treatments for Alzheimer’s disease which seem likely to appear in the next few years and results from a meeting of British experts in neurodegenerative diseases in Edinburgh. The